BIOLINERX     Print Page  Close Window

Investor relations home

BioLineRx is a clinical-stage biopharmaceutical company focused on oncology and immunology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

BioLineRx's leading therapeutic candidates are: BL-8040, a cancer therapy platform, which has successfully completed a Phase 2a study for relapsed/refrac... More >>

Therapeutic pipeline
Title
Download Documentation Pipeline
Upcoming events
DateTitle
11/21/17 10:00 a.m. ET
BioLineRx Q3 2017 Earnings Conference Call
Download Event Supporting Material Third Quarter 2017 Financial Results
12/05/17
Investor Breakfast 2017
12/09/17
ASH 2017
01/08/18
Biotech Showcase
02/12/18
BIO CEO
What's new
DateTitle
10/06/17
Download Documentation BioLineRx Company presentation
Get help downloading or viewing the above file types